Team Grant : Transnational Cardiovascular Research Projects
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Monday 30th, March 2020
External Deadline: Thursday 2nd, April 2020
Description
It is estimated that 55 million deaths occurred in the world in 2017, of which 1 7.7 million were from cardiovascular disease. Each year, cardiovascular diseases (CVD) cause 3.9 million deaths in the European continent and over 1.8 million deaths in the European Union (EU). Furthermore, these diseases are one of the leading causes of long-term sickness, chronic conditions and labour force loss due to disability, and thus pose a major health- and socio-economic problem in Europe and beyond. Based on a better understanding of the causes of CVD, the development of new diagnostic markers, medicinal products and the improvement in medical technologies requires innovative research based on scientific excellence. Cardiovascular research and its translation into better preventive, diagnostic and therapeutic outcomes are fundamental for patients in Europe and worldwide.
The ERA-NET on Cardiovascular Diseases (ERA-CVD) has been established under the ERA-NET scheme of the European Commission. The aim of ERA-CVD is to foster new, as well as to extend existing, transnational cooperation of European countries, and to coordinate research efforts and funding programmes of its partner countries.
Under the umbrella of ERA-CVD, the fifth joint transnational call JTC2020 is now launched to promote transnational research projects focusing on Prevention of Vascular Cognitive Impairment through Early Detection of Cardiovascular Diseases.
The call topic is based on mutual agreement between the ERA-CVD partners. The aim of the call is to enable scientists from different countries to come together and build effective collaborations on the early detection of CVD for the prevention of VCI.
Research should focus on the association between vascular precipitating or causative factors, and the molecular effectors to prevent the onset of VCI. Projects should have a clear translational research approach with a potential clinical impact.
Additional information can be found at Research Net.